Skip to content
Open Data Finder
Open Government Canada

Emergence of Desalkylgidazepam: A Novel Benzodiazepine in Canada

Published by Health Canada | Santé Canada

About this dataset

This short report provides quick statistics on Desalkylgidazepam, the most identified new psychoactive substance in Canada in 2022 based on samples submitted to the Drug Analysis Service by law enforcement agencies and public health partners.

Emergence of Desalkylgidazepam: A Novel Benzodiazepine in Canada · Open Data Finder